Statins have been linked with muscle pain and other musculoskeletal adverse events (MAEs) in some patients. A new Pharmacology Research & Perspectives study has examined the timing of MAEs that develop during statin therapy ...
Nov 7, 2018
0
0
A new University of Hertfordshire study found that using certain over-the-counter herbal medicines and dietary supplements alongside prescription drugs could pose serious health risks, especially amongst older adults.
Sep 25, 2018
1
46
A new review in SLAS Discovery explores how improved safety screening strategies and methods are improving the pharmaceutical discovery and development process. Terry R. Van Vleet et al. of AbbVie (Chicago, IL USA) outline ...
Sep 11, 2018
0
1
(HealthDay)—Physicians, pharmacists, and public health officials play an important role in educating individuals about the risks of impaired driving caused by marijuana or opioids, according to a report from the Governors ...
Aug 16, 2018
0
0
Chinese authorities are scrambling to defuse public outrage over a safety scandal involving rabies vaccines, just one of a string of food and drug scares to hit the country in recent years.
Jul 24, 2018
0
4
Safety is imperative before new medicines are given to patients – which is why drugs are tested on millions of animals worldwide each year to detect possible risks and side effects. But research shows computer simulations ...
Mar 27, 2018
0
1
(HealthDay)—Every day, more than 300 children are treated in U.S. emergency rooms for accidental poisoning, and two children die from it.
Mar 13, 2018
0
1
The frequency of adverse reactions to benznidazole is high when treating chronic Chagas patients, although the effects were mostly mild, according to a study led by ISGlobal, in collaboration with the Hospital Clinic of Barcelona. ...
Feb 21, 2018
0
8
(HealthDay)—Color-coded compartmentalized "rainbow trays" used for anesthetic drug preparation and storage may improve patient safety, according to a study published online Jan. 3 in Anaesthesia.
Jan 16, 2018
0
2
(HealthDay)—New evidence regarding safety is spurring the U.S. Food and Drug Administration to remove a Boxed Warning from certain inhaled medications used to treat asthma and chronic obstructive pulmonary disease.
Dec 26, 2017
0
27
